Efficacy of Atezolizumab in Subsequent Lines of Therapy for NSCLC Patients: Insights from Real-World Data

Milica Kontić, Filip Marković, Nikola Nikolić, Natalija Samardžić, Goran Stojanović, Petar Simurdić, Svetlana Petkov, Daliborka Bursać, Bojan Zarić, Mihailo Stjepanović, Nagio Takigawa · 2024

Read Efficacy of Atezolizumab in Subsequent Lines of Therapy for NSCLC Patients: Insights from Real-World Data by Milica Kontić, Filip Marković, Nikola Nikolić, Natalija Samardžić, Goran Stojanović, Petar Simurdić, Svetlana Petkov, Daliborka Bursać, Bojan Zarić, Mihailo Stjepanović, Nagio Takigawa (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11545278.txt.

Description

Simple SummaryThis study analyzes real-world outcomes for advanced, non-oncogene addicted non-small cell lung cancer patients treated with atezolizumab monotherapy following platinum-based chemotherapy, based on data from two academic institutions in Serbia. Progression-free survival did not significantly differ between patients receiving atezolizumab as a second, third, or later line of therapy, indicating consistent efficacy across treatment lines.

Catalog record

CREATORMilica Kontić, Filip Marković, Nikola Nikolić, Natalija Samardžić, Goran Stojanović, Petar Simurdić, Svetlana Petkov, Daliborka Bursać, Bojan Zarić, Mihailo Stjepanović, Nagio Takigawa
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11545278

Browse the full library · About the Tower of Babel